Altrius International ADR Div Income (S:0P0000ZNB5)
26.19
+0.08
(+0.30%)
USD |
Sep 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 30, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| BAE Systems Plc | 4.38% | 93.09 | -1.23% |
| Banco Bilbao Vizcaya Argentaria SA | 4.35% | 23.13 | -0.09% |
| Royal Bank of Canada | 4.27% | 235.18 | 0.57% |
| GSK Plc | 4.24% | 49.11 | 0.06% |
| BP Plc | 4.16% | 34.45 | 0.53% |
| Novartis AG | 4.13% | 139.20 | 0.01% |
| Nestlé SA | 3.95% | 99.43 | 0.96% |
| Siemens AG | 3.95% | 139.59 | -0.58% |
| AstraZeneca PLC | 3.93% | 92.52 | -0.41% |
| Roche Holding AG | 3.93% | 51.80 | -1.33% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |